Our study reveals that among the different types of monocytes, the CD14++CD16− subset is the key monocyte population producing inflammatory cytokines and, upon ART initiation, has a clearly differentiated trajectory, expanding in TB-IRIS patients and proportionally decreasing in non-IRIS patients. This evidence concerns the gene CD14 and tuberculosis.